Glycomimetics Inc (GLYC)

$0.16 -0.01 (-5.42%)
Market Cap 10.13M
Revenue (ttm) 0.00
Net Income (ttm) -37.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,069,300
Avg Vol 2,282,298
Day's Range N/A - N/A
Shares Out 64.53M
Stochastic %K 8%
Beta 1.62
Analysts Strong Sell
Price Target $1.00

Company Profile

GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.

Industry: Biotechnology
Sector: Healthcare
Phone: 240 243 1201
Address:
P.O. Box 65, Monrovia, United States
Latest News on GLYC
No data available.